Drug or treatment
Ubamatamab clinical trials
As of November 12, 2026, Find a Trial lists 4 clinical trials of Ubamatamab that are recruiting, at sites in 14 countries (most in United States (4), Belgium (2), France (2)). By phase: Phase 1/2 (2), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 14Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Ubamatamab with or without REGN7075 for adults with advanced or metastatic non-small cell lung cancer | Phase 2 | Birmingham, Alabama and 17 other locations | Recruiting | Sep 4, 2025 |
| Ubamatamab alone and with other cancer drugs for platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer | Phase 2 | Birmingham, Alabama and 55 other locations | Recruiting | Jan 22, 2025 |
| Investigating the safety and effectiveness of REGN5668 with other drugs for advanced ovarian and uterine cancers | Phase 1/2 | Duarte, California and 27 other locations | Recruiting | Oct 19, 2020 |
| Treatment for recurrent ovarian and other MUC16+ cancers using REGN4018 and cemiplimab | Phase 1/2 | Birmingham, Alabama and 53 other locations | Recruiting | Jun 20, 2018 |
All recruiting trials (4)
-
Ubamatamab with or without REGN7075 for adults with advanced or metastatic non-small cell lung cancer
This trial will try ubamatamab alone and with REGN7075 in adults with advanced or metastatic non-small cell lung cancer to see if they control the cancer and will try sarilumab to manage immune-related side effects.
-
Ubamatamab alone and with other cancer drugs for platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer
This trial will test whether ubamatamab by itself or combined with bevacizumab, cemiplimab, fianlimab, or pegylated liposomal doxorubicin helps adults with platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer.
-
Investigating the safety and effectiveness of REGN5668 with other drugs for advanced ovarian and uterine cancers
This study is testing if a new drug called REGN5668, used with other medications, can safely help people with advanced ovarian or uterine cancers.
-
Treatment for recurrent ovarian and other MUC16+ cancers using REGN4018 and cemiplimab
This study is testing if a new treatment combining REGN4018 and cemiplimab can help adults with recurrent ovarian and other MUC16+ cancers feel better when other options have run out.
Quick answers
How many clinical trials of Ubamatamab are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in United States (4 trials), Belgium (2 trials), France (2 trials), South Korea (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.